These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

414 related articles for article (PubMed ID: 33729209)

  • 1. Systematic review and meta-analysis of cannabinoids, cannabis-based medicines, and endocannabinoid system modulators tested for antinociceptive effects in animal models of injury-related or pathological persistent pain.
    Soliman N; Haroutounian S; Hohmann AG; Krane E; Liao J; Macleod M; Segelcke D; Sena C; Thomas J; Vollert J; Wever K; Alaverdyan H; Barakat A; Barthlow T; Bozer ALH; Davidson A; Diaz-delCastillo M; Dolgorukova A; Ferdousi MI; Healy C; Hong S; Hopkins M; James A; Leake HB; Malewicz NM; Mansfield M; Mardon AK; Mattimoe D; McLoone DP; Noes-Holt G; Pogatzki-Zahn EM; Power E; Pradier B; Romanos-Sirakis E; Segelcke A; Vinagre R; Yanes JA; Zhang J; Zhang XY; Finn DP; Rice ASC
    Pain; 2021 Jul; 162(Suppl 1):S26-S44. PubMed ID: 33729209
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Targeting the endocannabinoid system for management of HIV-associated neuropathic pain: A systematic review.
    Aly E; Masocha W
    IBRO Neurosci Rep; 2021 Jun; 10():109-118. PubMed ID: 34179865
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Cannabinoids, the endocannabinoid system, and pain: a review of preclinical studies.
    Finn DP; Haroutounian S; Hohmann AG; Krane E; Soliman N; Rice ASC
    Pain; 2021 Jul; 162(Suppl 1):S5-S25. PubMed ID: 33729211
    [TBL] [Abstract][Full Text] [Related]  

  • 4. A protocol for the systematic review and meta-analysis of studies in which cannabinoids were tested for antinociceptive effects in animal models of pathological or injury-related persistent pain.
    Soliman N; Hohmann AG; Haroutounian S; Wever K; Rice ASC; Finn DP
    Pain Rep; 2019; 4(4):e766. PubMed ID: 31579857
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Current evidence of cannabinoid-based analgesia obtained in preclinical and human experimental settings.
    Lötsch J; Weyer-Menkhoff I; Tegeder I
    Eur J Pain; 2018 Mar; 22(3):471-484. PubMed ID: 29160600
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Cannabis-based medicines for chronic neuropathic pain in adults.
    Mücke M; Phillips T; Radbruch L; Petzke F; Häuser W
    Cochrane Database Syst Rev; 2018 Mar; 3(3):CD012182. PubMed ID: 29513392
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Cannabinoids as pharmacotherapies for neuropathic pain: from the bench to the bedside.
    Rahn EJ; Hohmann AG
    Neurotherapeutics; 2009 Oct; 6(4):713-37. PubMed ID: 19789075
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Cannabis and cannabinoids for symptomatic treatment for people with multiple sclerosis.
    Filippini G; Minozzi S; Borrelli F; Cinquini M; Dwan K
    Cochrane Database Syst Rev; 2022 May; 5(5):CD013444. PubMed ID: 35510826
    [TBL] [Abstract][Full Text] [Related]  

  • 9. International Association for the Study of Pain Presidential Task Force on Cannabis and Cannabinoid Analgesia: research agenda on the use of cannabinoids, cannabis, and cannabis-based medicines for pain management.
    Haroutounian S; Arendt-Nielsen L; Belton J; Blyth FM; Degenhardt L; Di Forti M; Eccleston C; Finn DP; Finnerup NB; Fisher E; Fogarty AE; Gilron I; Hohmann AG; Kalso E; Krane E; Mohiuddin M; Moore RA; Rowbotham M; Soliman N; Wallace M; Zinboonyahgoon N; Rice ASC
    Pain; 2021 Jul; 162(Suppl 1):S117-S124. PubMed ID: 34138827
    [TBL] [Abstract][Full Text] [Related]  

  • 10. The Endogenous Cannabinoid System: A Budding Source of Targets for Treating Inflammatory and Neuropathic Pain.
    Donvito G; Nass SR; Wilkerson JL; Curry ZA; Schurman LD; Kinsey SG; Lichtman AH
    Neuropsychopharmacology; 2018 Jan; 43(1):52-79. PubMed ID: 28857069
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Alterations in endocannabinoid tone following chemotherapy-induced peripheral neuropathy: effects of endocannabinoid deactivation inhibitors targeting fatty-acid amide hydrolase and monoacylglycerol lipase in comparison to reference analgesics following cisplatin treatment.
    Guindon J; Lai Y; Takacs SM; Bradshaw HB; Hohmann AG
    Pharmacol Res; 2013 Jan; 67(1):94-109. PubMed ID: 23127915
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Targeting CB2 receptors and the endocannabinoid system for the treatment of pain.
    Anand P; Whiteside G; Fowler CJ; Hohmann AG
    Brain Res Rev; 2009 Apr; 60(1):255-66. PubMed ID: 19150370
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Antinociceptive effects of minor cannabinoids, terpenes and flavonoids in Cannabis.
    Rodriguez CEB; Ouyang L; Kandasamy R
    Behav Pharmacol; 2022 Apr; 33(2&3):130-157. PubMed ID: 33709984
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Endocannabinoid metabolism and uptake: novel targets for neuropathic and inflammatory pain.
    Jhaveri MD; Richardson D; Chapman V
    Br J Pharmacol; 2007 Nov; 152(5):624-32. PubMed ID: 17704819
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Balancing risks and benefits of cannabis use: umbrella review of meta-analyses of randomised controlled trials and observational studies.
    Solmi M; De Toffol M; Kim JY; Choi MJ; Stubbs B; Thompson T; Firth J; Miola A; Croatto G; Baggio F; Michelon S; Ballan L; Gerdle B; Monaco F; Simonato P; Scocco P; Ricca V; Castellini G; Fornaro M; Murru A; Vieta E; Fusar-Poli P; Barbui C; Ioannidis JPA; Carvalho AF; Radua J; Correll CU; Cortese S; Murray RM; Castle D; Shin JI; Dragioti E
    BMJ; 2023 Aug; 382():e072348. PubMed ID: 37648266
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Effects of cannabinoids and cannabinoid-enriched Cannabis extracts on TRP channels and endocannabinoid metabolic enzymes.
    De Petrocellis L; Ligresti A; Moriello AS; Allarà M; Bisogno T; Petrosino S; Stott CG; Di Marzo V
    Br J Pharmacol; 2011 Aug; 163(7):1479-94. PubMed ID: 21175579
    [TBL] [Abstract][Full Text] [Related]  

  • 17. The endocannabinoid hydrolysis inhibitor SA-57: Intrinsic antinociceptive effects, augmented morphine-induced antinociception, and attenuated heroin seeking behavior in mice.
    Wilkerson JL; Ghosh S; Mustafa M; Abdullah RA; Niphakis MJ; Cabrera R; Maldonado RL; Cravatt BF; Lichtman AH
    Neuropharmacology; 2017 Mar; 114():156-167. PubMed ID: 27890602
    [TBL] [Abstract][Full Text] [Related]  

  • 18. The effectiveness of cannabinoids in the management of chronic nonmalignant neuropathic pain: a systematic review.
    Boychuk DG; Goddard G; Mauro G; Orellana MF
    J Oral Facial Pain Headache; 2015; 29(1):7-14. PubMed ID: 25635955
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Endocannabinoids and pain: spinal and peripheral analgesia in inflammation and neuropathy.
    Rice AS; Farquhar-Smith WP; Nagy I
    Prostaglandins Leukot Essent Fatty Acids; 2002; 66(2-3):243-56. PubMed ID: 12052040
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Preclinical science regarding cannabinoids as analgesics: an overview.
    Lynch ME
    Pain Res Manag; 2005; 10 Suppl A():7A-14A. PubMed ID: 16237476
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 21.